Navigation Links
Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
Date:3/19/2008

Clinical Data Presented at SIR Meeting Indicates New Catheter-based Treatment Could Soon Become the Standard of Care for Treating Acute DVT

WASHINGTON, March 19 /PRNewswire/ -- Registry clinical data presented this week at the Society of Interventional Radiology's 33rd Annual Scientific Meeting shows DVT treatment with the Trellis(R) Peripheral Infusion System from Bacchus Vascular, Inc. (Santa Clara, CA) successfully breaks up the blood clot in most patients in about 20 minutes.

This technique restores blood flow more quickly and safely than current catheter-directed thrombolysis (CDT) techniques. It provides an important adjunct to the standard therapy of anti-coagulation alone, which is intended to prevent future clots but does not break up the existing clot.

Gerard O'Sullivan, MD, Interventional Radiologist from University Hospital in Galway, Ireland, reported the latest outcomes from the manufacturer's registry of clinical results of the Trellis catheter at over 360 hospitals in the U.S. and internationally.

In a total of 827 limbs treated in 771 patients, Grade II and III lysis with restoration of patency in patients with acute clot was achieved in 97% of cases. The vast majority of cases (> 80%) were completed in less than two hours in the single-setting of the interventional suite, and the usage of the Trellis catheter itself was typically around 20 minutes. Although required with CDT procedures, no follow-up monitoring in a costly critical care unit was typically needed with the Trellis catheter treatment.

There were no reported bleeding complications from the Trellis procedure in acute follow up and compared to CDT the dosage of thrombolytic drugs such as t-PA are appreciably reduced with use of the Trellis device.

"The single biggest change in treating DVT patients with the Trellis catheter is our ability to get the clot out and have the patients able to walk away immediately after the procedure," said Dr. O'Sullivan. "Literally, the patient comes into the procedure with difficulty or cannot walk and I can now walk them out of the procedure room at the end of the treatment. These patients are typically back to work in 2-3 days versus the 6-8 weeks with anticoagulation-only treatment."

About Bacchus Vascular

Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company's Trellis(R) Peripheral Infusion System and other products.

For more information, visit http://www.bacchusvascular.com


'/>"/>
SOURCE Bacchus Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Data Shows VNUS ClosureFAST(TM) Catheter More than 96% Effective
2. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
3. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
4. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
5. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
6. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
7. New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry
8. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
9. American Heart Association Journal Report: Reducing Kids Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks
10. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
11. Novel Small Molecule Therapy Shows Benefit for Anemic Patients Via Hydration of Red Blood Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
(Date:6/8/2017)... Responding to Heath Ledger,s father,s recent call for ... Chris Cornell in May, the mental health watchdog group, ... psychiatric drug side effects search engine ... risks. The father of the late actor ... has called for tighter rules on prescription drugs. Speaking at ...
(Date:6/5/2017)... , June 5, 2017 The Cincinnati ... of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded a ... Enquirer . Results are based on an employee ... organizational health and workplace improvement. The survey measures several aspects ... ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... ... 21 Middle East and South Asia Leaders Selected as Eisenhower Fellows , ... society in 11 countries across the Middle East and South Asia to embark on ... knowledge and ideas with the leading minds in their fields. , For the ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance Agency ( ... Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more people than ... Biggert-Waters Act was enacted to reflect the actual risk in flood zone areas ...
(Date:6/23/2017)... PA (PRWEB) , ... June 23, 2017 , ... ... insurance management, financial planning, and related services to families and business owners in ... a charity drive to benefit senior citizens in the area. , Meals on ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... financial planning to families and business owners in North Central West Virginia, is ... provide services to differently abled residents in the region. , The Stepping Stones ...
(Date:6/22/2017)... ... , ... Plastic Surgery Associates is proud to report that founding surgeon, Francisco ... and information firm, Castle Connolly, releases their list of the most notable and trusted ... time that Dr. Canales has been recognized by Castle Connolly. , ...
Breaking Medicine News(10 mins):